Citigroup
SRTA

Citigroup’s Strata Critical Medical Inc SRTA Stock Holding History

Citigroup’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$404K Sell
96,635
-1,559
-2% -$7.5K ﹤0.01% 3673
2025
Q4 		$472K Buy
98,194
+58,610
+148% +$283K ﹤0.01% 3600
2025
Q3 		$200K Buy
39,584
+14,079
+55% +$62.2K ﹤0.01% 3994
2025
Q2 		$103K Sell
25,505
-15,199
-37% -$49.5K ﹤0.01% 4394
2025
Q1 		$111K Sell
40,704
-4,090
-9% -$14.7K ﹤0.01% 4542
2024
Q4 		$190K Buy
44,794
+2,025
+5% +$7.71K ﹤0.01% 4445
2024
Q3 		$126K Buy
42,769
+29,560
+224% +$94.1K ﹤0.01% 4649
2024
Q2 		$46K Buy
13,209
+1,421
+12% +$4.74K ﹤0.01% 4631
2024
Q1 		$33.6K Buy
11,788
+2,721
+30% +$8.39K ﹤0.01% 4834
2023
Q4 		$32K Buy
9,067
+8,538
+1,614% +$24.5K ﹤0.01% 4760
2023
Q3 		$1.37K Sell
529
-17,397
-97% -$61.1K ﹤0.01% 5041
2023
Q2 		$70.6K Buy
17,926
+17,426
+3,485% +$55.3K ﹤0.01% 4431
2023
Q1 		$1.69K Sell
500
-382
-43% -$1.56K ﹤0.01% 5110
2022
Q4 		$3.16K Sell
882
-1,515
-63% -$6.47K ﹤0.01% 5135
2022
Q3 		$10K Sell
2,397
-2,670
-53% -$13.7K ﹤0.01% 4979
2022
Q2 		$23K Sell
5,067
-7,154
-59% -$51.6K ﹤0.01% 4911
2022
Q1 		$104K Sell
12,221
-32,604
-73% -$229K ﹤0.01% 4394
2021
Q4 		$395K Buy
44,825
+37,302
+496% +$355K ﹤0.01% 3948
2021
Q3 		$78K Buy
+7,523
New +$65.7K ﹤0.01% 4506
2021
Q1 		– Sell
-48,700
Closed -$540K – 6305
2020
Q4 		$540K Sell
48,700
-44,000
-47% -$449K ﹤0.01% 4141
2020
Q3 		$932K Hold
92,700
– – ﹤0.01% 3333
2020
Q2 		$924K Hold
92,700
– – ﹤0.01% 3635
2020
Q1 		$896K Buy
+92,700
New +$920K ﹤0.01% 3298

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's SRTA Position: Q1 2026 in Review

Citigroup reduced its Strata Critical Medical Inc (SRTA) stake by 1.6% in Q1 2026, selling an estimated $7.5K and leaving 96,635 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #3673.

Citigroup first reported a position in SRTA in Q1 2020 and has held it in 23 quarters since. The position peaked at $932K in Q3 2020. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Citigroup held 96,635 shares of Strata Critical Medical Inc worth $404K as of Q1 2026.
  • Citigroup sold 1,559 Strata Critical Medical Inc shares in Q1 2026, an estimated $7.5K.
  • Strata Critical Medical Inc made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3673 holding.
  • Citigroup first reported a position in Strata Critical Medical Inc in Q1 2020 and has held it in 23 quarters since.
  • Citigroup's Strata Critical Medical Inc position peaked at $932K in Q3 2020.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.